ArticleJournal of materials science. Materials in medicine2026
Arginine-loaded silica nanoparticles inhibit E. faecalis in root canals.
Article in Journal of materials science. Materials in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial infection of the root canal system, especially by Enterococcus faecalis (E. faecalis), is the primary cause of root canal treatment failure, and intracanal medication has been proven to be an effective method for controlling root canal infection. Mesoporous silica nanoparticles (MSNs) with their sponge-like structure, tunable particle size, surface functionalization, and favorable biocompatibility offer promise for intracanal drug delivery. This study evaluated the antibacterial efficacy of an arginine-loaded MSN system (MSN@Arg) against E. faecalis, its effects on osteogenic differentiation in MC3T3-E1 cells, and its ability to control infection within the root canal system. The physicochemical properties and drug release profile of MSN@Arg were assessed using electron microscopy and other analytical techniques. Antibacterial activity was evaluated through bacterial culture assays. Alkaline phosphatase and Alizarin Red staining were performed to evaluate osteogenic differentiation. An E. faecalis-infected root canal model was established in extracted teeth, and the antibacterial efficacy of MSN@Arg, chlorhexidine (CHX), and calcium hydroxide was compared at 3, 7, 14, and 21 days after drug sealing. The synthesized MSNs (diameter < 100 nm) exhibited extensive distribution within dentinal tubules. MSN@Arg enabled sustained and stable release of arginine, inhibited E. faecalis in both planktonic and biofilm states, and promoted ALP expression and mineralized nodule formation in MC3T3-E1 cells, with high biocompatibility. MSN@Arg demonstrated greater antibacterial efficacy than calcium hydroxide on days 3 and 7, was comparable to CHX on day 14, and slightly more effective than CHX on day 21. Given its deep penetration into dentinal tubules and sustained drug release capacity, MSN@Arg represents a promising agent for root canal disinfection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.